Laboratoires Pierre Fabre and XtalPi strike AI drug deal
November 9, 2026: Laboratoires Pierre Fabre and XtalPi announced a multi-program drug-discovery deal combining AI-designed molecules, robotics, milestone payments and downstream economic participation.